Boston Scientific Corporation (BSX)
How Well Is Boston Scientific Placed for Long-Term Endoscopy Growth?
BSX's Endoscopy unit targets an $8B market, spanning pancreaticobiliary, surgery and obesity, with plans to outgrow the market.
Should You Hold On To BSX Stock Despite Its Premium Valuation?
Boston Scientific trades at a premium, but strong momentum in WATCHMAN, EP and MedSurg growth keeps long-term shareholders in the game despite valuation risks.
Boston Scientific (BSX) Advances While Market Declines: Some Information for Investors
Boston Scientific (BSX) reached $94.48 at the closing of the latest trading day, reflecting a +1.65% change compared to its last close.
Is It Worth Investing in Boston Scientific (BSX) Based on Wall Street's Bullish Views?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Here's Why Boston Scientific (BSX) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
4 Medical Device Stocks to Buy for Healthy Returns in 2026
ISRG, PODD, BSX and IDXX lead medtech innovation with AI, robotics and diagnostics for growth in 2026.
Boston Scientific (BSX) Stock Falls Amid Market Uptick: What Investors Need to Know
The latest trading day saw Boston Scientific (BSX) settling at $91.75, representing a -1.02% change from its previous close.
Boston Scientific Sustains Momentum in the PFA Market: What's Next?
BSX builds momentum in PFA as FARAPULSE posts strong growth, and new trial results and expanded FDA labeling boost its AF treatment push.
Boston Scientific Corporation (BSX) Presents at Citi Annual Global Healthcare Conference 2025 Prepared Remarks Transcript
Boston Scientific Corporation (BSX) Presents at Citi Annual Global Healthcare Conference 2025 Prepared Remarks Transcript
M&A Strategy Strengthens Boston Scientific's Growth Prospects
BSX accelerates growth as a wave of acquisitions boosts core portfolios and fuels expansion into high-growth adjacent markets.
Why Boston Scientific (BSX) is a Top Momentum Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Is Boston Scientific (BSX) a Buy as Wall Street Analysts Look Optimistic?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
